Nomad Foods Limited · NYSE:NOMD
Nomad Foods — Q1 2025 Earnings Presentation
19 slides from Nomad Foods's earnings presentation, May 8, 2025
Slide 1: First Quarter 2025 Earnings Results
FIRST QUARTER 2025 Earnings Results May 8, 2025
Slide 2: Disclaimer
Disclaimer This Presentation has been prepared and issued by Nomad Foods Limited (the “Company”). This Presentation has been provided solely for information and background. The information in this Presentation is provided as at the date of the Presentation (unless stated otherwise). This Presentatio
Slide 3: First Quarter Highlights
First Quarter Highlights • Organic growth (-3.6%) lagged retail sell-through (+0.2%) on larger-than-expected retail inventory destocking and Easter timing. • Strong gross margin expansion (+90 bps YoY) helped fund continued reinvestment in A&P (+dd YoY). • Adjusted EBITDA declined 1.8% YoY in 1Q25 a
Slide 4: Category Growth is Strong & has Accelerated
Category Growth is Strong & has Accelerated 4 Source: NielsenIQ & Circana
Slide 5: Market Share Growth Slowed as Expected on Timing of Initiatives
Market Share Growth Slowed as Expected on Timing of Initiatives Inflated | Deflated by seasonal timing shifts in the measured period. 5 Source: NielsenIQ & Circana
Slide 6: 2025 Big News: Elevating our Fish Portfolio
2025 Big News: Elevating our Fish Portfolio 6
Slide 7: First Quarter 2025 Key Financial Metrics
First Quarter 2025 Key Financial Metrics Adjusted Total Revenue Adjusted Gross Margin EBITDA** EPS** €760m 27.8% €120m €0.35 -3.6% +90 bps YoY $0.40* organic** *Q1 25 Adjusted EPS converted to USD, the currency in which Nomad Foods shares trade, for illustrative purposes and based on USD/EUR FX rate
Slide 8: First Quarter 2025 Key Operating Highlights
First Quarter 2025 Key Operating Highlights (in €m other than EPS) 1Q 2025 1Q 2024 YoY Change Revenue €760 €784 (3.0)% Organic revenue growth/(decline)* (3.6)% Gross profit 212 211 —% Gross margin 27.8% 26.9% 90 bp Adjusted operating expense* (116) (112) 3% Depreciation & amortization 24 23 4% Adjus
Slide 9: 2025 YTD Free Cash Flow Highlights
2025 YTD Free Cash Flow Highlights 3 months ended 3 months ended (in €m) March 31, 2025 March 31, 2024 Adjusted EBITDA* €120 €122 Change in working capital (40) 11 Capital expenditures1 (20) (19) Cash taxes (12) (9) Cash interest & other2 (35) (56) Adjusted free cash flow* €13 €49 Adjusted profit fo
Slide 10: Updated 2025 Guidance
Updated 2025 Guidance Organic Revenue Adjusted EBITDA** Adjusted EPS** Adjusted Free Cash Flow Conversion** 0-2% 0-2% €1.82 - €1.89 90%+ growth growth 2-6% growth (+1-3% prior) (+2-4% prior) (€1.85-€1.89 prior) $2.07 - $2.15* 10 *2025 Adjusted EPS guidance range converted to USD, the currency in whi
Slide 11: Questions?
Questions?
Slide 12: Appendix
Appendix
Slide 13: Contents
Contents The following tables have been included to allow users to reconcile Non-IFRS financial measures as well as Adjusted financial information included within this presentation to reported IFRS financial measures. 1. Definitions of Non-IFRS financial measures referred to in this presentation. 2.
Slide 14: Definitions of Non-IFRS Financial Measures
1. Definitions of Non-IFRS financial measures referred to in this presentation Non-IFRS financial measures should not be considered as substitutes for, or superior to, measures of financial performance prepared in accordance with IFRS. They are limited in value because they exclude charges that have
Slide 15: Reconciliation of Non-IFRS Financial Measures
2. Reconciliation of Non-IFRS Financial Measures Reconciliation from reported to organic revenue growth/(decline) The following table is a reconciliation of reported revenue growth to Organic Revenue Growth for the three month period ended March 31, 2025. Year on Year Growth - March 31, 2025 compare
Slide 16: Reconciliation of Non-IFRS Financial Measures
2. Reconciliation of Non-IFRS Financial Measures (continued) Adjusted Statement of Profit or Loss (unaudited) Three Months Ended March 31, 2025 As reported for the three As adjusted for the three € in millions, except per share data months ended March 31, Adjustments months ended March 31, 2025 2025
Slide 17: Reconciliation of Non-IFRS Financial Measures
2. Reconciliation of Non-IFRS Financial Measures (continued) Adjusted Statement of Profit or Loss (unaudited) Three Months Ended March 31, 2024 As reported for the three As adjusted for the three € in millions, except per share data months ended March 31, Adjustments months ended March 31, 2024 2024
Slide 18: Reconciliation of Non-IFRS Financial Measures
2. Reconciliation of Non-IFRS Financial Measures (continued) Reconciliation of Profit for the period to Adjusted EBITDA (unaudited) Three months ended € in millions March 31, 2025 March 31, 2024 Profit for the period 32.7 34.5 Taxation 7.0 7.4 Net financing costs 34.1 30.1 Depreciation & amortizatio
Slide 19: Reconciliation of Non-IFRS Financial Measures
2. Reconciliation of Non-IFRS Financial Measures (continued) Reconciliation of reported net cash flows from operating activities to Adjusted free cash flow for the three months ended March 31, 2025 and the three months ended March 31, 2024. Three months ended Three months ended (in €m) March 31, 202